Borderline Personality Disorder Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
Condition: Borderline Personality Disorder Interventions: Drug: vafidemstat; Drug: Placebo Sponsor: Oryzon Genomics S.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2021 Category: Research Source Type: clinical trials

Assessing the efficacy of a stepped-care group treatment programme for borderline personality disorder: study protocol for a pragmatic trial
DiscussionThis pragmatic trial will provide valuable information regarding the effectiveness of a progressive stepped-care group treatment for individuals with BPD in the real-world setting of a community mental health service. It will further the current understanding of variables that predict treatment dose and duration.Trial registrationAustralian New Zealand Clinical Trials RegistryACTRN12618000477224. Registered on 3 April 2018 (Source: Trials)
Source: Trials - June 7, 2021 Category: Research Source Type: clinical trials

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
Conditions: Depressive Disorder, Major; Borderline Personality Disorder Interventions: Device: Left Dorsolateral Prefrontal Cortex (L-DLPFC); Device: Dorsomedial Prefrontal Cortex (DMPFC); Device: Sham Stimulation Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2021 Category: Research Source Type: clinical trials